Global radiotherapy market is projected to witness a CAGR of 7.93% during the forecast period to grow from US$7.526 billion in 2018 to US$11.896 billion in 2024. The global radiotherapy market growth is expected to be driven by the reduction in treatment cost, the increase in cancer cases, large scale investments in R&D for cancer treatments and the development of non-invasive procedures for treatment. The factors such as availability of alternative therapy, inability to be used for metastasis state of cancer and side effects like skin rashes are likely to hinder the global radiotherapy market.
The report provides a brief introduction of the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segments which have been covered as part of the report.
This section provides comprehensive market dynamics through an overview section along with growth drivers, challenges and opportunities which exist in the current market. This section of the report also provides global and regional regulations which are determining the market growth and industry value chain analysis of the global radiotherapy market. Complete industry analysis has also been covered through Porter’s five forces model as a part of this report section.
The major players discussed in this report include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications (IBA), Nordion, Inc., C. R. Bard, Inc., Isoray Medical, Inc., RaySearch Laboratories, Mevion Medical Systems, Inc., and Mitsubishi Electric Corporation.
In the report, the global radiotherapy market has been segmented by therapy type, by application, by end-user, and geography:
By Therapy Type
External Beam Radiotherapy
Internal Beam Radiotherapy/Brachytherapy
Head and Neck Cancer
Ambulatory Surgical Centres
Middle East and Africa (MEA)
Asia Pacific (APAC)